Australia TGA ARTG recordIrrigation fluid, nasal
Australia TGA ARTG Registered Device · Arrotex Pharmaceuticals Pty Ltd · Cipla Limited · Class I · Started February 01, 2018
Good Name: Arrotex Pharmaceuticals Pty Ltd - Irrigation fluid, nasal
- Risk Class
- Class I
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- February 01, 2018
- Effective Date
- February 01, 2018
- Name
- Cipla Limited
- Country
- India
- Address
- Plot No 9 & 10 Pharma Zone, Phase II Sector III Indore Special Economic Zone, Pithampur District Dhar, Madhya Pradesh, 454-775
Nasal Spray is a PH buffered, isotonic saline solution that provides relief for mild to moderate nasal congestion due to colds & flu, hayfever, rhinitis and sinusitis. A saline solution, used to penetrate, clear and clean the nasal passages and sinus cavity. clears nasal passages, helps breathe easier naturally. soothes dry nasal passages. provide relief from sinusitis and hayfever. washes away germs, pollutants, dust, pollen and other allergens. effective for post operative nasal care.
Access comprehensive regulatory information for Irrigation fluid, nasal in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by Arrotex Pharmaceuticals Pty Ltd, manufactured by Cipla Limited in India. The device registration started on February 01, 2018.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.